Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Potential antipsychotics under development at Taisho/Nihon Nohyaku

Sep. 16, 1997

Mitsubishi describes synthesis and activity of MKC-242

Sep. 15, 1997

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Cardiovascular effects of SB-209509 and sumatriptan compared in dogs

Sep. 15, 1997

Amphetamines may provide long-term benefit in patients with ADHD

Sep. 15, 1997

Kyowa Hakko antiparkinsonian enters phase II trials

Sep. 15, 1997

Preclinical studies show broad antiseizure properties of ganaxolone

Sep. 15, 1997

Capases: a new target for neurodegenerative disease therapy

Sep. 12, 1997

Essential tremor gene located by Icelandic genomics company

Sep. 12, 1997

Focus on Alzheimer's disease research in the U.S.

Sep. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...